tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Alexandria Hammond, 7 are a SELL (53.85%), 2 are a HOLD (15.38%), 4 are a BUY (30.77%).
Analyst Alexandria Hammond, currently employed at BAML, carries an average stock price target met ratio of 93.33% that have a potential upside of 19.72% achieved within 88 days. Previously, Alexandria Hammond worked at WOLFE.
Alexandria Hammond’s has documented 25 price targets and ratings displayed on 5 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on MRNA, Moderna at 18-Aug-2026.
Analyst best performing recommendations are on MRNA (MODERNA).
The best stock recommendation documented was for MRNA (MODERNA) at 11/15/2024. The price target of $40 was fulfilled within 7 days with a profit of $3.15 (8.55%) receiving and performance score of 12.21.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 04-Sep-2024
$123
$-23.12 (-15.82%)
$120
Buy Since 06-Oct-2025
$170
$23.88 (16.34%)
$170
Buy Since 22-Apr-2025
$155
$8.88 (6.08%)
$155
Buy Since 12-Feb-2025
$165
$18.88 (12.92%)
$166
Buy Since 24-Nov-2025
$156
$9.88 (6.76%)
$157
Which stock is Alexandria Hammond is most bullish on?
Which stock is Alexandria Hammond is most reserved on?
What Year was the first public recommendation made by Alexandria Hammond?
